Puviindran Nadesan Selected Research

Puviindran Nadesan Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 05/2002
5	Wounds and Injuries (Trauma) 01/2017 - 05/2002
5	Aggressive Fibromatosis (Desmoid) 10/2010 - 05/2002
4	Chondrosarcoma 01/2023 - 01/2006
3	Chondroma (Enchondroma) 01/2023 - 01/2006
3	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 05/2014
3	Cicatrix (Scar) 06/2014 - 02/2004
2	Bone Fractures (Bone Fracture) 01/2019 - 01/2017
2	Neoplastic Processes 08/2004 - 02/2004
1	Hypoxia (Hypoxemia) 01/2023
1	Tibial Fractures (Fracture, Tibial) 01/2019
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2017
1	Enchondromatosis (Ollier Disease) 03/2015
1	Carcinogenesis 10/2010
1	Shock 09/2010
1	Synovial Chondromatosis (Synovial Osteochondromatosis) 06/2005
1	Polyps 05/2002

Drug/Important Bio-Agent (IBA)

5	beta CateninIBA 08/2007 - 05/2002
4	CateninsIBA 01/2017 - 09/2010
3	TCF Transcription FactorsIBA 06/2014 - 08/2004
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 03/2015
2	CollagenIBA 09/2010 - 08/2004
2	Coloring Agents (Dyes)IBA 09/2007 - 08/2007
2	TriparanolIBA 01/2006 - 06/2005
1	GlycogenIBA 01/2023
1	EnzymesIBA 01/2023
1	Essential Amino AcidsIBA 01/2022
1	GlutaminaseIBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2021
1	Diphtheria ToxinIBA 11/2021
1	ApolipoproteinsIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	chondroitin sulfate proteoglycan 4IBA 01/2018
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2018
1	Narcotics (Narcotic Analgesics)IBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Nefopam (Ajan)IBA 01/2017
1	Tamoxifen FDA LinkGeneric 03/2015
1	IPI-926IBA 05/2014
1	LigandsIBA 05/2014
1	aniline blueIBA 09/2010
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 09/2007
1	RhodaminesIBA 09/2007
1	Hedgehog ProteinsIBA 01/2006
1	Parathyroid Hormone-Related ProteinIBA 01/2006
1	Transcription Factors (Transcription Factor)IBA 06/2005
1	Proteins (Proteins, Gene)FDA Link 06/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2005
1	Plasminogen Activator Inhibitor 1IBA 02/2005
1	Matrix Metalloproteinases (MMPs)IBA 08/2004
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2004
1	Conditioned Culture MediaIBA 08/2004
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 08/2004
1	matrigelIBA 08/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2004
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2004
1	beta-Galactosidase (Lactaid)IBA 02/2004
1	Epidermal Growth Factor (EGF)IBA 02/2004

Therapy/Procedure

2	Therapeutics 08/2007 - 08/2004
1	Immunotherapy 01/2018
1	Lasers (Laser) 09/2010
1	Transplantation 09/2007
1	Subcutaneous Injections 02/2004